Prescient Therapeutics CEO Yatomi-Clarke Steps Down; Will Remain Available as a Consultant

Investing.com 09/12 07:55

Prescient Therapeutics "an ASX-listed Oncology Drug Developer With a Big FY25 Ahead", Says Pitt Street Research

Investing.com 09/05 07:54

Prescient Therapeutics Ltd：付録4Eと2024年報告書

08/26 07:54

Prescient Therapeutics Refines Phase 2 PTX-100 Trial Design for Greater Success

Investing.com 07/31 11:35

Prescient Therapeutics Appoints Accomplished Medical Professional Dr Gavin Shepherd as a Director

Investing.com 07/04 12:28

We're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash Wisely

Yahoo Finance03/06 08:48